BRK-B vs IROQ
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
IROQ presents as a classic value play, trading below its Graham Number ($31.52) and Intrinsic Value ($31.90) with a Price-to-Book ratio of 0.99. However, a Piotroski F-Score of 4/9 indicates only stable financial health, and the technical trend is currently bearish (0/100). While revenue and earnings growth remain positive at approximately 8%, the low ROE (6.33%) and ROA (0.60%) suggest inefficient capital utilization. The lack of analyst coverage and negligible dividend yield further temper the bullish value case.
Compare Another Pair
Related Comparisons
BRK-B vs IROQ: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and IF Bancorp Inc (IROQ) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.